Background
About Us
Research
News & Events
Contact Us
More
Please find our current list of recent publications:
Abdel-Hafiz, H.A., Schafer, J.M., Chen, X. et al. Y chromosome loss in cancer drives growth by evasion of adaptive immunity. Nature (2023).
Theodorescu, D., Li, Z., and Li, X. (2022). Sex in bladder cancer: emerging data and call to action. Nat Rev Urol.
Lam, C.M., Li, Z., Theodorescu, D., and Li, X. Mechanism of Sex Differences in Bladder Cancer: Evident and Elusive Sex-biasing Factors. Bladder Cancer. 2022 Sept 15;8(3):241-254. doi: 10.3233/BLC-211658. PMID: 36277328; PMCID: PMC9536425.
Zhang, Y., Theodorescu, D., and Li, X. (2021). Gender Disparities in Bladder Cancer. In Modern Approach to Diagnosis and Treatment of Bladder Cancer, F. ziglioli and U. Maestroni, eds. (London, IntechOpen).
Kaneko, S., and Li, X. (2018). X chromosome protects against bladder cancer in females via a KDM6A-dependent epigenetic mechanism. Sci Adv 4, eaar5598.
Kwon H, Schafer JM, Song NJ, Kaneko S, Li A, Xiao T, Ma A, Allen C, Das K, Zhou L, Riesenberg B, Chang Y, Weltge P, Velegraki M, Oh DY, Fong L, Ma Q, Sundi D, Chung D, Li X, Li Z. Androgen conspires with the CD8+ T cell exhaustion program and contributes to sex bias in cancer. Sci Immunol. 2022 Jul;7(73):eabq2630. doi: 10.1126/sciimmunol.abq2630. Epub 2022 Jul 1. PMID: 35420889; PMCID: PMC9374385.
Kwon, H., Lin, C.Y., Chung, D., Li, X., and Li, Z. (2018). Sex as a predictor of response to cancer immunotherapy. The Lancet Oncology 19, e379.
Lin, C.Y., Kwon, H., Rangel Rivera, G.O., Li, X., Chung, D., and Li, Z. (2018). Sex Differences in Using Systemic Inflammatory Markers to Prognosticate Patients with Head and Neck Squamous Cell Carcinoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 27, 1176-1185.
Metelli, A., Salem, M., Wallace, C.H., Wu, B.X., Li, A., Li, X., and Li, Z. (2018). Immunoregulatory functions and the therapeutic implications of GARP-TGF-beta in inflammation and cancer. J Hematol Oncol 11, 24.
Overdevest, J.B., Knubel, K.H., Duex, J.E., Thomas, S., Nitz, M.D., Harding, M.A., Smith, S.C., Frierson, H.F., Conaway, M., and Theodorescu, D. (2012). CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated. Proc Natl Acad Sci U S A 109, E3588-3596.